Replies to post #486366 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

Brain shrinkage data isn't a primary or secondary trial endpoint and in that regard then not directly relevant for approval - but is most likely include the EMA submission.

[abew4me]

test